TXMD vs. SCHD
Compare and contrast key facts about TherapeuticsMD, Inc. (TXMD) and Schwab US Dividend Equity ETF (SCHD).
SCHD is a passively managed fund by Charles Schwab that tracks the performance of the Dow Jones U.S. Dividend 100 Index. It was launched on Oct 20, 2011.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: TXMD or SCHD.
Correlation
The correlation between TXMD and SCHD is 0.25, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
TXMD vs. SCHD - Performance Comparison
Key characteristics
TXMD:
-1.23
SCHD:
1.15
TXMD:
-2.09
SCHD:
1.70
TXMD:
0.77
SCHD:
1.20
TXMD:
-0.54
SCHD:
1.63
TXMD:
-1.70
SCHD:
5.55
TXMD:
31.93%
SCHD:
2.33%
TXMD:
44.21%
SCHD:
11.24%
TXMD:
-99.99%
SCHD:
-33.37%
TXMD:
-99.99%
SCHD:
-6.45%
Returns By Period
In the year-to-date period, TXMD achieves a -51.33% return, which is significantly lower than SCHD's 11.86% return. Over the past 10 years, TXMD has underperformed SCHD with an annualized return of -41.00%, while SCHD has yielded a comparatively higher 10.89% annualized return.
TXMD
-51.33%
-20.07%
-39.50%
-52.60%
-61.16%
-41.00%
SCHD
11.86%
-5.88%
6.68%
12.28%
11.08%
10.89%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
TXMD vs. SCHD - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for TherapeuticsMD, Inc. (TXMD) and Schwab US Dividend Equity ETF (SCHD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
TXMD vs. SCHD - Dividend Comparison
TXMD has not paid dividends to shareholders, while SCHD's dividend yield for the trailing twelve months is around 3.63%.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
TXMD TherapeuticsMD, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
SCHD Schwab US Dividend Equity ETF | 3.63% | 3.49% | 3.39% | 2.78% | 3.16% | 2.98% | 3.06% | 2.63% | 2.89% | 2.97% | 2.63% | 2.47% |
Drawdowns
TXMD vs. SCHD - Drawdown Comparison
The maximum TXMD drawdown since its inception was -99.99%, which is greater than SCHD's maximum drawdown of -33.37%. Use the drawdown chart below to compare losses from any high point for TXMD and SCHD. For additional features, visit the drawdowns tool.
Volatility
TXMD vs. SCHD - Volatility Comparison
TherapeuticsMD, Inc. (TXMD) has a higher volatility of 11.70% compared to Schwab US Dividend Equity ETF (SCHD) at 3.73%. This indicates that TXMD's price experiences larger fluctuations and is considered to be riskier than SCHD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.